| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Muralidhar Bali is a Director at EXICURE, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $126.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | XCUR Exicure, Inc. | Director | Buy | 1,472,126 | $0.19 | $285,150.81 | +21.1% | -37.2% | -73.3% | |
| Jul 14, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 111,736 | $8.50 | $949,756.00 | +5.7% | -22.3% | -65.2% | |
| Jun 23, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 20,710 | $9.28 | $192,244.72 | +1.1% | -18.7% | -75.9% | |
| Jun 22, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 47,274 | $8.94 | $422,413.74 | +1.2% | -11.4% | -74.8% | |
| Jun 8, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 16,605 | $9.50 | $157,709.31 | +0.9% | -7.8% | -76.1% | |
| Jun 4, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 12,357 | $9.26 | $114,365.17 | +0.3% | -6.4% | -77.1% | |
| May 28, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 14 | $9.50 | $133.00 | - | -37.5% | -79.3% | |
| May 27, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 7,035 | $9.36 | $65,864.42 | +0.2% | -27.1% | -78.5% | |
| Apr 13, 2021 | OKUR Onkure Therapeutics, Inc. | Director | Buy | 200,000 | $15.00 | $3,000,000.00 | +12.1% | -26.7% | -77.4% | |
| Oct 14, 2020 | SPRB Spruce Biosciences, Inc. | Director | Buy | 200,000 | $15.00 | $3,000,000.00 | +12.6% | - | - |